Shakir Ali Selected Research

borax

10/2020	Boron improves cardiac contractility and fibrotic remodeling following myocardial infarction injury.
3/2006	Boron ameliorates fulminant hepatic failure by counteracting the changes associated with the oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shakir Ali Research Topics

Disease

12	Neoplasms (Cancer) 10/2022 - 10/2010
8	Inflammation (Inflammations) 02/2021 - 03/2004
7	Infections 02/2021 - 03/2004
5	Body Weight (Weight, Body) 10/2020 - 06/2012
3	Hypoglycemia (Reactive Hypoglycemia) 02/2021 - 12/2013
3	Fibrosis (Cirrhosis) 10/2020 - 03/2005
3	Wounds and Injuries (Trauma) 05/2017 - 03/2005
3	Carcinoma (Carcinomatosis) 01/2015 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 11/2020
2	Tuberculosis (Tuberculoses) 01/2022 - 08/2013
2	Malaria 02/2021 - 12/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 02/2019 - 08/2013
2	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2012 - 12/2011
2	Acute Liver Failure (Fulminant Hepatic Failure) 03/2006 - 04/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022
1	Latent Tuberculosis 01/2022
1	Hypertension (High Blood Pressure) 02/2021
1	Myocardial Infarction 10/2020
1	Lung Neoplasms (Lung Cancer) 09/2019
1	Coinfection 02/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Filariasis 03/2017
1	Fatty Liver 01/2017
1	Disease Progression 05/2016
1	Colonic Neoplasms (Colon Cancer) 04/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 02/2021 - 05/2012
4	BoronIBA 10/2020 - 03/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2011
3	Protein Isoforms (Isoforms)IBA 10/2022 - 12/2013
3	Pharmaceutical PreparationsIBA 02/2021 - 12/2014
3	LycopeneIBA 01/2014 - 10/2010
3	Scorpion Venoms (Scorpion Venom)IBA 12/2011 - 02/2011
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
2	CarrageenanIBA 02/2021 - 06/2012
2	boraxIBA 10/2020 - 03/2006
2	Blood Glucose (Blood Sugar)IBA 07/2020 - 04/2013
2	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2017
2	AntioxidantsIBA 01/2019 - 01/2017
2	CytokinesIBA 05/2017 - 08/2013
2	AntigensIBA 03/2017 - 12/2013
2	Drinking WaterIBA 12/2014 - 12/2013
2	Glucose (Dextrose)FDA LinkGeneric 12/2013 - 08/2013
2	Mixed Function Oxygenases (Monooxygenases)IBA 01/2013 - 03/2008
2	4,6-dinitro-o-cresol (DNOC)IBA 01/2013 - 03/2008
2	MolybdenumIBA 01/2013 - 03/2008
2	Okadaic AcidIBA 09/2012 - 12/2011
2	Donepezil (Aricept)FDA LinkGeneric 09/2012 - 12/2011
2	Memantine (Namenda)FDA Link 09/2012 - 12/2011
2	VenomsIBA 12/2011 - 02/2011
2	NF-kappa B (NF-kB)IBA 10/2010 - 03/2004
1	Adenosine Triphosphate (ATP)IBA 10/2022
1	xanthoneIBA 10/2022
1	Phosphotransferases (Kinase)IBA 10/2022
1	AndrogensIBA 10/2022
1	GlucosidesIBA 10/2022
1	Glycogen Synthase KinasesIBA 10/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	1,2,4-triazoleIBA 02/2021
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 02/2021
1	SodiumIBA 10/2020
1	SaltsIBA 10/2020
1	HexokinaseIBA 07/2020
1	Toll-Like Receptor AgonistsIBA 09/2019
1	AllergensIBA 09/2019
1	Cancer VaccinesIBA 09/2019
1	VaccinesIBA 09/2019
1	Cytochrome P-450 CYP2C9IBA 02/2019
1	Antitubercular AgentsIBA 02/2019
1	Dapsone FDA Link 02/2019
1	Bupropion (Wellbutrin)FDA LinkGeneric 02/2019
1	Losartan (Cozaar)FDA LinkGeneric 02/2019
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 02/2019
1	IsoflavonesIBA 01/2019
1	GenisteinIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017
1	Epidermal Growth Factor (EGF)IBA 05/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2017
1	Ointments (Pastes)IBA 05/2017
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 05/2017
1	CollagenIBA 05/2017
1	AntibodiesIBA 03/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Interleukin-8 (Interleukin 8)IBA 05/2016
1	Messenger RNA (mRNA)IBA 05/2016
1	Inflammation MediatorsIBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	QuinazolinesIBA 04/2015

Therapy/Procedure

4	Therapeutics 10/2022 - 01/2019
4	Drug Therapy (Chemotherapy) 01/2019 - 12/2013
3	Intraperitoneal Injections 01/2014 - 03/2005
1	Radiotherapy 01/2019
1	Integrative Oncology 01/2019
1	Art Therapy 05/2016